FENC Fennec Pharmaceuticals Inc.

NASDAQ
$11.62

Fennec Pharmaceuticals Inc. (FENC) Earnings News

Earnings press releases, previews and reviews for Fennec Pharmaceuticals Inc. (FENC), newest first. Our most recent is review: Fennec Pharmaceuticals Converts PEDMARK Momentum Into a 30% EBITDA Margin, Even as Year-Over-Year Growth Cools and Guidance Stays Absent.